Elon Musk’s neurotechnology company, Neuralink, was granted U.S. Food and Drug Administration (FDA) approval to test its device in humans, according to an announcement posted to Twitter on Thursday. The company has not provided specifics on an anticipated study and regulators have not confirmed or denied the approval, which has not yet been listed on the government’s clinical trials database. However, FDA Press Officer, Carly Kempler said in an email that she “acknowledges and understands” that Neuralink had made the announcement.Read More
Elon Musk’s Neuralink Gets FDA Approval to Implant Brain-Tech Into Humans
